Stock Groups

U.S. administers more than 400 million doses of COVID-19 vaccines

by Mike Robinson

[ad_1]

© Reuters. FILEPHOTO: Ashlyn, an OSU student, gets her second dose from Pfizer’s coronavirus (COVID-19), vaccine in a Columbus clinic, Ohio. This was September 15, 2021. REUTERS/Gaelen Morse/File Photo

(Reuters) – As of Friday morning the United States had administered 469,422 COVID-19 shots in the country and given 485,713,525 of them, U.S. Centers for Disease Control and Prevention reported.

These figures represent an increase from Thursday’s 399,552,444 vaccination doses that the CDC stated had reached arms. This is in addition to 482,326,275 vaccine doses.

It stated that 216.573,911 persons had been given at least one dose of vaccines, and that 186.917.921 people were complete vaccinated as per the agency’s estimates. This was according to ET on Friday, 6:06 a.m. ET, Friday

The CDC tally also includes vaccines of two doses Moderna (NASDAQ:) and Pfizer/BioNTech, as well as Johnson & Johnson (NYSE:)’s one-shot vaccine.

Roughly 7.3 million people have received booster doses of either Pfizer Moderna’s vaccine (NYSE:) since August 13, 2013, when the U.S. approved a third dose for those with compromised immune systems, who may have less protection than the two-dose regimens.

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



[ad_2]